Delivery Order SPE2DR25D1004-SPE2DR26FSUP3
Award Date 11/6/25
Potential Completion Date 11/7/25
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,994.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on August 27, 2025, with an ultimate completion date of August 28, 2025. This non-competitive delivery order was executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injectors in 0.5 mL quantities, with a contract ceiling value of $32,050.85. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and...
- The Defense Logistics Agency awarded a $7,428.28 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 11, 2025, and performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a branded semaglutide injection used in diabetes and weight management treatment, consistent...
- The Defense Logistics Agency awarded a delivery order valued at $14,239.24 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors on September 15, 2025, with completion targeted for September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide injection used for weight management and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,064.50 for Zepbound 7.5 mg/0.5 ml pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a branded semaglutide injection used for weight management and represents...
- The Defense Logistics Agency Medical Supply Chain awarded a $14,214.34 delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections with a completion date of July 17, 2025. This is a firm fixed price, non-set-aside delivery order issued under a child contract arrangement, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location. Zepbound is a semaglutide-based pharmaceutical product used for weight...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injections, valued at $6,035.72. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist...
- The Defense Logistics Agency awarded a delivery order valued at $15,238.13 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on August 27, 2025, with completion scheduled for August 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based medication primarily used for weight...
- The Defense Logistics Agency awarded a delivery order valued at $2,240.96 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injections on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based medication used for weight management, and...
- The Defense Logistics Agency awarded a delivery order valued at $4,068.68 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based injectable medication used for weight...